Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Smith Nephew ADR Representing 2 Ord Shs C.SNN


Primary Symbol: SNN

Healthcare Medical Devices
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


NYSE:SNN - Post by User

Smith Nephew ADR Representing 2 Ord Shs > Another SNN article quote, “UNDERVALUED”
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Bluechip2on Dec 06, 2018 8:53am
213 Views
Post# 29074514

RE:RE:RE:Another SNN article quote, “UNDERVALUED”

RE:RE:RE:Another SNN article quote, “UNDERVALUED”@Bluesguy- short seller panick, today is the day we are squeezing the shorts. Has everyone checked out the latest photos from the construction in Cathedral City? Looks like they will have 4-5 bays operational 1st quarter and the stockpiles of oils for the branding launch in January is scary big, the photos of oil are unavailable for material reasons but check out photos here: https://discord.gg/MZ2k7M

Without a doubt, Sunniva will have the highest sales in California, by far, in 2019. Do your due diligence, time is running at hand.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities